Showing results (1101-1110 of 1,165) with videos related to

Sort By:
Pageof 117
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
Circulation|August 27, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER TrialJawad H Butt, Pardeep S Jhund, Jan Belohlávek, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
Journal of the American Heart Association|June 15, 2017
Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection FractionChester L Drum, Warren K Y Tan, Siew-Pang Chan, et al.
European Heart Journal|August 30, 2025
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trialJaved Butler, Francesco Fioretti, Ciaran J McMullan, et al.
Circulation|November 7, 2022
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVERXiaowen Wang, Muthiah Vaduganathan, Brian L Claggett, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 3, 2019
The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failureBernadet T Santema, Michelle M Y Chan, Jasper Tromp, et al.
European Journal of Heart Failure|August 25, 2017
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitorsJaved Butler, Carine E Hamo, Gerasimos Filippatos, et al.
European Journal of Heart Failure|June 14, 2024
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HFGeert Voordes, Beth Davison, Jan Biegus, et al.
Pageof 117